Advertisement
Screener

ONKURE THERAPEUTICS, INC. (OKUR) Cash Flow Breakdown

ONKURE THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where ONKURE THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $51.83M went out.
  • Fiscal year ended 2025-12-31: from investing, $46.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $163.00K came in.
  • Fiscal year ended 2025-12-31: change in cash, $51.71M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$51.83M-$46.00K$240.00K-$51.71M
2024-12-31-$51.12M$15.87M$26.00K$116.10M*$80.89M
2023-12-31-$34.55M-$246.00K$53.13M*$18.33M
2022-12-31-$47.36M-$57.84M$193.00K-$104.73M
2021-12-31-$37.98M-$23.38M$84.61M$47.79M*$71.05M
2020-12-31-$18.54M$7.38M$87.00K$47.19M*$36.11M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$10.35M*-$9.87M*-$5.38M*
2026-03-31-$12.94M-$5.00K$146.00M*$133.06M
2025-12-31-$11.51M*-$9.00K*
2025-09-30-$13.04M*-$6.00K*
2025-06-30-$13.27M*-$13.00K*
2025-03-31-$14.01M-$18.00K-$14.10M
2024-12-31-$23.35M*$15.91M*$110.25M*
2024-09-30-$10.66M*-$18.00K*
2024-06-30-$6.47M*-$10.00K*$5.87M*
2024-03-31-$10.63M-$9.00K-$10.63M
2023-12-31$9.38M*$29.01M*-$11.87M*
2023-09-30-$18.77M*$21.25M*
2023-06-30-$16.11M*-$69.01M*$63.81M*
2023-03-31-$9.05M$18.51M$1.01M$10.47M
2022-12-31-$15.61M*-$26.92M*
2022-09-30-$10.79M*-$45.44M*
2022-06-30-$11.96M*$9.08M*
2022-03-31-$9.00M$5.43M$6.00K-$3.57M
2021-12-31-$10.02M*$8.15M*-$29.00K*
2021-09-30-$9.67M*-$4.51M*$2.00K*
2021-06-30-$9.70M*-$27.00M*$84.45M*$1.39M*
2021-03-31-$8.59M-$25.00K$187.00K$46.03M*$37.61M
2020-12-31-$5.41M*-$16.00K*$10.00K*$47.19M*
2020-09-30-$5.74M*$1.19M*$51.00K*
2020-06-30-$2.94M*$1.00M*$0.00*
2020-03-31-$4.45M$5.20M$26.00K$778.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
Immuneering Corp (IMRX)United States$0.113B-12.51
Quantum Cyber N.V. (QUCY)$0.113B
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
GENELUX Corp (GNLX)United States$0.110B-3.83
Equillium, Inc. (EQ)United States$0.109B-11.27